ID   NPT2C_HUMAN             Reviewed;         599 AA.
AC   Q8N130; A2BFA1;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   10-MAY-2017, entry version 115.
DE   RecName: Full=Sodium-dependent phosphate transport protein 2C;
DE            Short=Sodium-phosphate transport protein 2C;
DE   AltName: Full=Na(+)-dependent phosphate cotransporter 2C;
DE   AltName: Full=Sodium/inorganic phosphate cotransporter IIC;
DE   AltName: Full=Sodium/phosphate cotransporter 2C;
DE            Short=Na(+)/Pi cotransporter 2C;
DE            Short=NaPi-2c;
DE   AltName: Full=Solute carrier family 34 member 3;
GN   Name=SLC34A3; Synonyms=NPT2C, NPTIIC;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND VARIANT VAL-513.
RC   TISSUE=Kidney;
RX   PubMed=11880379; DOI=10.1074/jbc.M200943200;
RA   Segawa H., Kaneko I., Takahashi A., Kuwahata M., Ito M., Ohkido I.,
RA   Tatsumi S., Miyamoto K.;
RT   "Growth-related renal type II Na/Pi cotransporter.";
RL   J. Biol. Chem. 277:19665-19672(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-513.
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [4]
RP   VARIANTS HHRH PHE-138; LEU-192; ARG-196 AND TRP-468, AND VARIANT
RP   VAL-513.
RX   PubMed=16358214; DOI=10.1086/499409;
RA   Bergwitz C., Roslin N.M., Tieder M., Loredo-Osti J.C., Bastepe M.,
RA   Abu-Zahra H., Frappier D., Burkett K., Carpenter T.O., Anderson D.,
RA   Garabedian M., Sermet I., Fujiwara T.M., Morgan K., Tenenhouse H.S.,
RA   Jueppner H.;
RT   "SLC34A3 mutations in patients with hereditary hypophosphatemic
RT   rickets with hypercalciuria predict a key role for the sodium-
RT   phosphate cotransporter NaPi-IIc in maintaining phosphate
RT   homeostasis.";
RL   Am. J. Hum. Genet. 78:179-192(2006).
RN   [5]
RP   VARIANTS HHRH LEU-192; LEU-353 AND GLU-413, AND VARIANTS HIS-67;
RP   ALA-180; ASN-237; SER-337 AND VAL-513.
RX   PubMed=16358215; DOI=10.1086/499410;
RA   Lorenz-Depiereux B., Benet-Pages A., Eckstein G.,
RA   Tenenbaum-Rakover Y., Wagenstaller J., Tiosano D., Gershoni-Baruch R.,
RA   Albers N., Lichtner P., Schnabel D., Hochberg Z., Strom T.M.;
RT   "Hereditary hypophosphatemic rickets with hypercalciuria is caused by
RT   mutations in the sodium-phosphate cotransporter gene SLC34A3.";
RL   Am. J. Hum. Genet. 78:193-201(2006).
CC   -!- FUNCTION: May be involved in actively transporting phosphate into
CC       cells via Na(+) cotransport in the renal brush border membrane.
CC       Probably mediates 20-30% of the apical influx.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=79 uM for phosphate {ECO:0000269|PubMed:11880379};
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- DISEASE: Hereditary hypophosphatemic rickets with hypercalciuria
CC       (HHRH) [MIM:241530]: Autosomal recessive form of hypophosphatemia
CC       characterized by reduced renal phosphate reabsorption and rickets.
CC       Increased serum levels of 1,25-dihydroxyvitamin D lead to increase
CC       in urinary calcium excretion. {ECO:0000269|PubMed:16358214,
CC       ECO:0000269|PubMed:16358215}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: A 2:1 stoichiometry to Na(+)/Pi is observed at pH
CC       7.4.
CC   -!- SIMILARITY: Belongs to the SLC34A transporter family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB055000; BAB83242.1; -; mRNA.
DR   EMBL; AK095999; BAC04667.1; -; mRNA.
DR   EMBL; BX255925; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS7038.1; -.
DR   RefSeq; NP_001170787.1; NM_001177316.1.
DR   RefSeq; NP_001170788.1; NM_001177317.1.
DR   RefSeq; NP_543153.1; NM_080877.2.
DR   RefSeq; XP_016869781.1; XM_017014292.1.
DR   UniGene; Hs.432442; -.
DR   ProteinModelPortal; Q8N130; -.
DR   BioGrid; 126771; 1.
DR   STRING; 9606.ENSP00000355353; -.
DR   TCDB; 2.A.58.1.3; the phosphate:na(+) symporter (pnas) family.
DR   iPTMnet; Q8N130; -.
DR   PhosphoSitePlus; Q8N130; -.
DR   BioMuta; SLC34A3; -.
DR   DMDM; 313104149; -.
DR   EPD; Q8N130; -.
DR   PaxDb; Q8N130; -.
DR   PeptideAtlas; Q8N130; -.
DR   PRIDE; Q8N130; -.
DR   DNASU; 142680; -.
DR   Ensembl; ENST00000361134; ENSP00000355353; ENSG00000198569.
DR   Ensembl; ENST00000538474; ENSP00000442397; ENSG00000198569.
DR   GeneID; 142680; -.
DR   KEGG; hsa:142680; -.
DR   UCSC; uc004cmf.1; human.
DR   CTD; 142680; -.
DR   DisGeNET; 142680; -.
DR   GeneCards; SLC34A3; -.
DR   HGNC; HGNC:20305; SLC34A3.
DR   HPA; HPA023776; -.
DR   MalaCards; SLC34A3; -.
DR   MIM; 241530; phenotype.
DR   MIM; 609826; gene.
DR   neXtProt; NX_Q8N130; -.
DR   OpenTargets; ENSG00000198569; -.
DR   Orphanet; 157215; Hereditary hypophosphatemic rickets with hypercalciuria.
DR   PharmGKB; PA134930298; -.
DR   eggNOG; ENOG410IE8P; Eukaryota.
DR   eggNOG; COG1283; LUCA.
DR   GeneTree; ENSGT00390000005032; -.
DR   HOGENOM; HOG000006550; -.
DR   HOVERGEN; HBG006527; -.
DR   InParanoid; Q8N130; -.
DR   KO; K14683; -.
DR   OMA; NCGAFGP; -.
DR   OrthoDB; EOG091G0DR5; -.
DR   PhylomeDB; Q8N130; -.
DR   TreeFam; TF313981; -.
DR   Reactome; R-HSA-427589; Type II Na+/Pi cotransporters.
DR   ChiTaRS; SLC34A3; human.
DR   GeneWiki; SLC34A3; -.
DR   GenomeRNAi; 142680; -.
DR   PRO; PR:Q8N130; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000198569; -.
DR   CleanEx; HS_SLC34A3; -.
DR   Genevisible; Q8N130; HS.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:HGNC.
DR   GO; GO:0005903; C:brush border; IBA:GO_Central.
DR   GO; GO:0031526; C:brush border membrane; IEA:InterPro.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0031982; C:vesicle; IBA:GO_Central.
DR   GO; GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005436; F:sodium:phosphate symporter activity; IDA:UniProtKB.
DR   GO; GO:0030643; P:cellular phosphate ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0006817; P:phosphate ion transport; IDA:UniProtKB.
DR   GO; GO:0006814; P:sodium ion transport; IDA:UniProtKB.
DR   InterPro; IPR003841; Na/Pi_transpt.
DR   InterPro; IPR029850; Na/Pi_transpt_2C.
DR   PANTHER; PTHR10010; PTHR10010; 1.
DR   PANTHER; PTHR10010:SF39; PTHR10010:SF39; 1.
DR   Pfam; PF02690; Na_Pi_cotrans; 2.
DR   TIGRFAMs; TIGR01013; 2a58; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; Disulfide bond; Glycoprotein;
KW   Ion transport; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Sodium; Sodium transport; Symport; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN         1    599       Sodium-dependent phosphate transport
FT                                protein 2C.
FT                                /FTId=PRO_0000068617.
FT   TOPO_DOM      1     76       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     77     97       Helical; Name=M1. {ECO:0000255}.
FT   TOPO_DOM     98    111       Extracellular. {ECO:0000255}.
FT   TRANSMEM    112    132       Helical; Name=M2. {ECO:0000255}.
FT   TOPO_DOM    133    188       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical; Name=M3. {ECO:0000255}.
FT   TOPO_DOM    210    322       Extracellular. {ECO:0000255}.
FT   TRANSMEM    323    343       Helical; Name=M4. {ECO:0000255}.
FT   TOPO_DOM    344    367       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    368    388       Helical; Name=M5. {ECO:0000255}.
FT   TOPO_DOM    389    445       Extracellular. {ECO:0000255}.
FT   TRANSMEM    446    466       Helical; Name=M6. {ECO:0000255}.
FT   TOPO_DOM    467    485       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    486    506       Helical; Name=M7. {ECO:0000255}.
FT   TOPO_DOM    507    510       Extracellular. {ECO:0000255}.
FT   TRANSMEM    511    531       Helical; Name=M8. {ECO:0000255}.
FT   TOPO_DOM    532    599       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    424    427       Poly-Thr.
FT   MOD_RES       4      4       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8K4R8}.
FT   CARBOHYD    265    265       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    268    268       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    286    286       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    299    299       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    276    309       {ECO:0000250}.
FT   VARIANT      67     67       R -> H (in dbSNP:rs34372115).
FT                                {ECO:0000269|PubMed:16358215}.
FT                                /FTId=VAR_025706.
FT   VARIANT     138    138       S -> F (in HHRH; dbSNP:rs141734934).
FT                                {ECO:0000269|PubMed:16358214}.
FT                                /FTId=VAR_025707.
FT   VARIANT     180    180       G -> A (in dbSNP:rs35643193).
FT                                {ECO:0000269|PubMed:16358215}.
FT                                /FTId=VAR_025708.
FT   VARIANT     192    192       S -> L (in HHRH; dbSNP:rs199690076).
FT                                {ECO:0000269|PubMed:16358214,
FT                                ECO:0000269|PubMed:16358215}.
FT                                /FTId=VAR_025709.
FT   VARIANT     196    196       G -> R (in HHRH; dbSNP:rs121918237).
FT                                {ECO:0000269|PubMed:16358214}.
FT                                /FTId=VAR_025710.
FT   VARIANT     237    237       D -> N (in dbSNP:rs145877051).
FT                                {ECO:0000269|PubMed:16358215}.
FT                                /FTId=VAR_025711.
FT   VARIANT     337    337       G -> S (in dbSNP:rs35699762).
FT                                {ECO:0000269|PubMed:16358215}.
FT                                /FTId=VAR_025712.
FT   VARIANT     353    353       R -> L (in HHRH; dbSNP:rs121918234).
FT                                {ECO:0000269|PubMed:16358215}.
FT                                /FTId=VAR_025713.
FT   VARIANT     413    413       A -> E (in HHRH; dbSNP:rs121918235).
FT                                {ECO:0000269|PubMed:16358215}.
FT                                /FTId=VAR_025714.
FT   VARIANT     468    468       R -> W (in HHRH; dbSNP:rs121918238).
FT                                {ECO:0000269|PubMed:16358214}.
FT                                /FTId=VAR_025715.
FT   VARIANT     513    513       E -> V (in dbSNP:rs28542318).
FT                                {ECO:0000269|PubMed:11880379,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:16358214,
FT                                ECO:0000269|PubMed:16358215}.
FT                                /FTId=VAR_025716.
SQ   SEQUENCE   599 AA;  63550 MW;  3747DE33D0A53E95 CRC64;
     MPSSLPGSQV PHPTLDAVDL VEKTLRNEGT SSSAPVLEEG DTDPWTLPQL KDTSQPWKEL
     RVAGRLRRVA GSVLKACGLL GSLYFFICSL DVLSSAFQLL GSKVAGDIFK DNVVLSNPVA
     GLVIGVLVTA LVQSSSTSSS IVVSMVAAKL LTVRVSVPII MGVNVGTSIT STLVSMAQSG
     DRDEFQRAFS GSAVHGIFNW LTVLVLLPLE SATALLERLS ELALGAASLT PRAQAPDILK
     VLTKPLTHLI VQLDSDMIMS SATGNATNSS LIKHWCGTTG QPTQENSSCG AFGPCTEKNS
     TAPADRLPCR HLFAGTELTD LAVGCILLAG SLLVLCGCLV LIVKLLNSVL RGRVAQVVRT
     VINADFPFPL GWLGGYLAVL AGAGLTFALQ SSSVFTAAVV PLMGVGVISL DRAYPLLLGS
     NIGTTTTALL AALASPADRM LSALQVALIH FFFNLAGILL WYLVPALRLP IPLARHFGVV
     TARYRWVAGV YLLLGFLLLP LAAFGLSLAG GMELAAVGGP LVGLVLLVIL VTVLQRRRPA
     WLPVRLRSWA WLPVWLHSLE PWDRLVTRCC PCNVCSPPKA TTKEAYCYEN PEILASQQL
//
